Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other financing activities: 2009-2025

Historic Other financing activities for UNITED THERAPEUTICS (UTHR) over the last 8 years, with Jun 2025 value amounting to $11.5 million.

  • UNITED THERAPEUTICS's Other financing activities was N/A to $11.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $24.4 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q2 2025, UNITED THERAPEUTICS's Other financing activities is $11.5 million, which was up 325.93% from $2.7 million recorded in Q1 2024.
  • UNITED THERAPEUTICS's Other financing activities' 5-year high stood at $11.5 million during Q2 2025, with a 5-year trough of $2.7 million in Q1 2023.
  • For the 3-year period, UNITED THERAPEUTICS's Other financing activities averaged around $5.6 million, with its median value being $2.7 million (2024).
  • Data for UNITED THERAPEUTICS's Other financing activities shows a maximum YoY tumbled of 64.00% (in 2023) over the last 5 years.
  • UNITED THERAPEUTICS's Other financing activities (Quarterly) stood at $7.5 million in 2022, then plummeted by 64.00% to $2.7 million in 2023, then remained steady at $2.7 million in 2024, then reached $11.5 million in 2025.
  • Its Other financing activities was $11.5 million in Q2 2025, compared to $2.7 million in Q1 2024 and $2.7 million in Q1 2023.